Literature DB >> 30137364

Heterozygous Mutations in TBX1 as a Cause of Isolated Hypoparathyroidism.

Dong Li1, Christopher T Gordon2,3, Myriam Oufadem2,3, Jeanne Amiel2,3,4, Harsh S Kanwar5, Marina Bakay1, Tiancheng Wang1, Hakon Hakonarson1,6, Michael A Levine5,6,7.   

Abstract

Context: Most cases of autosomal dominant isolated hypoparathyroidism are caused by gain-of-function mutations in CASR or GNA11 or dominant negative mutations in GCM2 or PTH. Objective: To identify the genetic etiology for dominantly transmitted isolated hypoparathyroidism in two multigenerational families with 14 affected family members.
Methods: We performed whole exome sequencing of DNA from two families and examined the consequences of mutations by minigene splicing assay.
Results: We discovered disease-causing mutations in both families. A splice-altering mutation in TBX1 (c.1009+1G>C) leading to skipping of exon 8 (101 bp) was identified in 10 affected family members and five unaffected subjects of family A, indicating reduced penetrance for this point mutation. In a second family from France (family B), we identified another splice-altering mutation (c.1009+2T>C) adjacent to the mutation identified in family A that results in skipping of the same exon; two subjects in family B had isolated hypoparathyroidism, whereas a third subject manifested the clinical triad of the 22q11.2 deletion syndrome, indicative of variable expressivity. Conclusions: We report evidence that heterozygous TBX1 mutations can cause isolated hypoparathyroidism. This study adds knowledge to the increasingly expanding list of causative and candidate genes in isolated hypoparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30137364      PMCID: PMC6194809          DOI: 10.1210/jc.2018-01260

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  48 in total

1.  Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions.

Authors:  Christiane Zweier; Heinrich Sticht; Inci Aydin-Yaylagül; Christine E Campbell; Anita Rauch
Journal:  Am J Hum Genet       Date:  2007-01-18       Impact factor: 11.025

2.  Germline mutations affecting Gα11 in hypoparathyroidism.

Authors:  Michael Mannstadt; Mark Harris; Bert Bravenboer; Sridhar Chitturi; Koen M A Dreijerink; David G Lambright; Elaine T Lim; Mark J Daly; Stacey Gabriel; Harald Jüppner
Journal:  N Engl J Med       Date:  2013-06-27       Impact factor: 91.245

3.  Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome.

Authors:  Ruti Parvari; Eli Hershkovitz; Nili Grossman; Rafael Gorodischer; Bart Loeys; Alexandra Zecic; Geert Mortier; Simon Gregory; Reuven Sharony; Marios Kambouris; Nadia Sakati; Brian F Meyer; Aida I Al Aqeel; Abdul Karim Al Humaidan; Fatma Al Zanhrani; Abdulrahman Al Swaid; Johara Al Othman; George A Diaz; Rory Weiner; K Tahseen S Khan; Ronald Gordon; Bruce D Gelb
Journal:  Nat Genet       Date:  2002-10-21       Impact factor: 38.330

4.  Familial isolated hypoparathyroidism: a molecular genetic analysis of 8 families with 23 affected persons.

Authors:  T G Ahn; S E Antonarakis; H M Kronenberg; T Igarashi; M A Levine
Journal:  Medicine (Baltimore)       Date:  1986-03       Impact factor: 1.889

5.  Positional cloning of the APECED gene.

Authors:  K Nagamine; P Peterson; H S Scott; J Kudoh; S Minoshima; M Heino; K J Krohn; M D Lalioti; P E Mullis; S E Antonarakis; K Kawasaki; S Asakawa; F Ito; N Shimizu
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

6.  Mice overexpressing genes from the 22q11 region deleted in velo-cardio-facial syndrome/DiGeorge syndrome have middle and inner ear defects.

Authors:  B Funke; J A Epstein; L K Kochilas; M M Lu; R K Pandita; J Liao; R Bauerndistel; T Schüler; H Schorle; M C Brown; J Adams; B E Morrow
Journal:  Hum Mol Genet       Date:  2001-10-15       Impact factor: 6.150

Review 7.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

8.  The zebrafish van gogh mutation disrupts tbx1, which is involved in the DiGeorge deletion syndrome in humans.

Authors:  Tatjana Piotrowski; Dae-gwon Ahn; Thomas F Schilling; Sreelaja Nair; Ilya Ruvinsky; Robert Geisler; Gerd-Jörg Rauch; Pascal Haffter; Leonard I Zon; Yi Zhou; Helen Foott; Igor B Dawid; Robert K Ho
Journal:  Development       Date:  2003-10       Impact factor: 6.868

9.  Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: cast a wide FISHing net!

Authors:  D M McDonald-McGinn; M K Tonnesen; A Laufer-Cahana; B Finucane; D A Driscoll; B S Emanuel; E H Zackai
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

10.  Tbx1 controls the morphogenesis of pharyngeal pouch epithelia through mesodermal Wnt11r and Fgf8a.

Authors:  Chong Pyo Choe; J Gage Crump
Journal:  Development       Date:  2014-08-19       Impact factor: 6.868

View more
  5 in total

Review 1.  Intratumor heterogeneity in human parathyroid tumors.

Authors:  C Verdelli; G S Tavanti; S Corbetta
Journal:  Histol Histopathol       Date:  2020-05-29       Impact factor: 2.303

2.  Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders.

Authors:  Lucie Canaff; Vito Guarnieri; Yoojung Kim; Betty Y L Wong; Alexis Nolin-Lapalme; David E C Cole; Salvatore Minisola; Cristina Eller-Vainicher; Filomena Cetani; Andrea Repaci; Daniela Turchetti; Sabrina Corbetta; Alfredo Scillitani; David Goltzman
Journal:  Eur J Endocrinol       Date:  2022-02-04       Impact factor: 6.664

3.  Multiple Recurrent Copy Number Variations (CNVs) in Chromosome 22 Including 22q11.2 Associated with Autism Spectrum Disorder.

Authors:  Safiah Alhazmi; Maryam Alzahrani; Reem Farsi; Mona Alharbi; Khloud Algothmi; Najla Alburae; Magdah Ganash; Sheren Azhari; Fatemah Basingab; Asma Almuhammadi; Amany Alqosaibi; Heba Alkhatabi; Aisha Elaimi; Mohammed Jan; Hesham M Aldhalaan; Aziza Alrafiah; Aisha Alrofaidi
Journal:  Pharmgenomics Pers Med       Date:  2022-07-20

4.  A Novel TBX1 Variant Causing Hypoparathyroidism and Deafness.

Authors:  Malak Alghamdi; Reem Al Khalifah; Doua K Al Homyani; Waleed H Alkhamis; Stefan T Arold; Aishah Ekhzaimy; Mohammed El-Wetidy; Tarek Kashour; Rabih Halwani
Journal:  J Endocr Soc       Date:  2019-11-29

5.  T-box transcription factor TBX1, targeted by microRNA-6727-5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways.

Authors:  Haixia Liu; Mei Song; Xiaoyan Sun; Xin Zhang; Huayan Miao; Yankui Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.